Advertisement

Topics

Companies Related to "Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients" [Most Relevant Company Matches] - Page: 3 RSS

22:01 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Human Lactoferrin hLF1 Treatment Infectious Complications Among" Companies 51–75 of 6,700+

Relevant

Total Safety

Total Safety, a DLJ Merchant Banking Partners portfolio company, based in Houston, Texas, is the world’s leading global provider of integrated safety strategies and the products necessary to support them: on-site safety services, turnaround safety support, gas detection, respiratory services, rescue services, safety training, fire services and engineered ...


Immunex Corporation

Immunex Corporation is a biopharmaceutical company that discovers, develops, manufactures and markets innovative therapeutic products for the treatment of human diseases, including cancer, infectious diseases and immunological disorders such as rheumatoid arthritis. American Home Products Corporation (AHP), through one of its wholly owned subsidiaries, American Cyanamid Company (CYANAMID), owns ap...

Biosynexus

Biosynexus Incorporated is a biopharmaceutical company that is commercializing a portfolio of products for the prevention and treatment of infectious diseases. The company has focused its initial efforts on developing products for the prevention and treatment of hospital acquired – nosocomial – staphylococcal infections


Contagion®

Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets and Outbreak Monitor, we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treat...

ImmunoVaccine Technologies Inc

ImmunoVaccine Technologies Inc. (IVT) is a company based in Halifax, Nova Scotia, Canada, commercializing a proprietary vaccine technology, VacciMax®.Proprietary Vaccine Enhancement Technology .ImmunoVaccine Technologies, Inc. (IVT) is the owner of the patented VacciMax® Platform that delivers long duration of immunity in a single administration, without boosting or significant side effects. The...

Ergonomics and Safety

Ergonomics and Safety provides consulting services to companies for prevention of occupational injuries and illnesses. Ergonomics and Safety applies the following ergonomics tools to industrial and office environments for workplace design and development of safety programs

Adenovir Pharma AB

Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes. Adenovir Pharma was founded by researchers at the department of Virology, Umeå University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma is located in Helsingborg Sweden in one of Europ...

Immunotech Laboratories, Inc.

Headquartered in Monrovia, CA, Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company strives to become a leader in immuno-therapeutic treatment and prevention of HIV/AIDS, Cancer and other immuno related disorders.

Advanced BioScience Laboratories, Inc. (ABL)

Profectus is a clinical-stage biotechnology company developing novel vaccines to prevent and treat major chronic viral infectious diseases and associated cancers for which standard of care is inadequate or nonexistent, as well as emerging infectious diseases of public health and biodefense importance. Profectus vaccines are based on the company’s prop...

Advanced Discovries for Health

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using our internal discovery capabilities and our network of pharmaceutical and academic partners, we have assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract inf...

PharmAbcine Inc.

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-house developed novel platform, DIG-Body, PIG-Body and TIG-Body using innovative discovery technology and excellent human resources for the treatment of human diseases, such as ca...

EBR Systems, Inc.

EBR Systems is dedicated to superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless endocardial pacing. The company’s patented, proprietary technology was developed to eliminate the need for cardiac pacing leads, historically the major source of complications and reliability issues in cardiac ...

PLANTON GmbH

Infectious diseases are the most frequent causes of death. Microbial resistance to antibiotics is an increasing problem in medical treatment and thus an important focus in pharmaceutical research. PLANTON develops and produces a novel class of antiinfectiva – antimicrobial peptides. These molecules have a strong antibiotic efficacy and a special mechanism avoiding resistance of human pathogens. ...

Baxter International

Baxter's BioScience business provides biopharmaceuticals derived from human plasma or recombinant technology to treat hemophilia, immune deficiencies and other blood-related disorders. It also provides vaccines for the prevention and treatment of certain infectious diseases, as well as biosurgery products. Baxter's breadth and depth of expertise in recombinant protein manufacturing, plasma fractio...

Gemmus Pharma Inc.

Gemmus is a privately held biotechnology company focused on the development of innovative pharmaceutical products for the treatment of infectious diseases by modulating the host response to the disease. Gemmus was founded in 2007 to develop EP2 and EP4 agonists for the treatment for the treatment of influenza and in-licensed technology from a major pharmac...

ARA Safety

ARA Safety is a world leader in innovative fire and life safety technology. ARA Safety's revolutionary Fire Interruption Technology (FIT) fire knock down tool is saving lives and reducing property loss in cities and towns across North America.

Fraunhofer USA CMB

Fraunhofer USA CMB, a division of Fraunhofer USA, Inc., is a not-for-profit research organization whose mission is to develop safe and effective vaccines targeting infectious diseases and autoimmune disorders. CMB’s technology provides a safe, rapid and economical alternative for vaccine production. The Center conducts research in the area of plant bi...

Viral Genetics

Viral Genetics is developing immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. The Company’s primary product candidate is VGV-1, an investigational therapy for the treatment of HIV/AIDS that has demonstrated an antiviral effect in clinical trials with an apparent immunological mechanism of action. VGV-1 is a suspension ...

National Genetics Institute

National Genetics Institute (NGI), a wholly owned subsidiary of Laboratory Corporation of America, provides advanced clinical testing services to the biopharmaceutical industry and medical providers utilizing sophisticated applied genetics techniques. NGI has developed industry-leading assays for human immunodeficiency virus (HIV), hepatitis viruses A, B, and C (HAV, HBV, and HCV) and other infec...

Mymetics Corporation

Mymetics' primary objective is to develop vaccines and therapies to prevent and treat the effects of certain retroviruses and other infectious diseases, including the human immunodeficiency virus, or HIV, the virus that leads to acquired immunodeficiency syndrome, or AIDS. Mymetics has also recently acquired from a close scientific partner an advanced malaria vaccine project currently in phase...

Probably Relevant

Vical

Vical is developing gene-based pharmaceutical products for human therapy. Vical's patented naked DNA gene delivery technology and proprietary lipids are designed to deliver selected genes into some cells in the body. These genes have been shown in clinical trials to cause the cells to produce desired proteins which may prevent or treat infectious and malignant diseases and other disorders. Vical i...

Juvaris BioTherapeutics, Inc.

Juvaris is a virtual biotech company with licensees advancing its Cationic Lipid-DNA Complex (CLDC) technology to develop adjuvanted vaccines and immunotherapeutics to treat infectious diseases and cancer in the fields of human health (Colby) and animal health (Bayer AG). The Company licensed animal health rights to Bayer AG in 2008 and human health (non-a...

institut merieux

With extensive experience in industrial microbiology, Institut Merieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, and food safety and nutrition.

Intarcia Therapeutics, Inc

Intarcia Therapeutics, Inc. is a biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. Our highly experienced team uses its expertise in clinical medicine, pharmaceutical development and regulatory affairs to identify and develop new uses or alternative formulat...

Actinova Limited

Innovative biopharmaceutical products targeted at infectious and non-infectious diseases. Emphasis placed on protein engineering and development of streptoccocal vaccines.Subsidiary of Actinova AB Sweden.


More From BioPortfolio on "Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks